Literature DB >> 36016592

Time to act: Early experience suggests stabilization care offers a feasible approach for adolescents after acute life-threatening opioid toxicity.

Eva M Moore1, Tom Warshawski2, Sara Jassemi1, Grant Charles3, Dzung X Vo1.   

Abstract

British Columbia is the epicentre of the opioid crisis in North America. Illicit drug toxicity is now one of the top 3 causes of death for adolescents in British Columbia. Evidence informed treatment is available but adolescents rarely receive it. Non-fatal toxicity can provide an opportunity to intervene. Since 2018, paediatricians in British Columbia have been offering admission, involuntary if necessary, to adolescents presenting to hospital after a life-threatening illicit drug toxicity. This brief stay, termed "stabilization care," offers medical and psychiatric assessments, withdrawal management and initiation of opioid agonist therapy and discharge planning. Hospital policies, procedures and protocols were revised to support the unique needs of this population. Early experience with 17 adolescents shows relatively high attachment to treatment services and opioid agonist treatment, suggesting that paediatric interdisciplinary teams, working strategically, can improve care for adolescents in the face of the opioid epidemic.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adolescents; Illicit drug; Opioid epidemic; Opioids; Substance use; Toxicity

Year:  2022        PMID: 36016592      PMCID: PMC9394634          DOI: 10.1093/pch/pxac034

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.600


  11 in total

Review 1.  Treatment and relapse prevention for adolescent substance abuse.

Authors:  Steven L Jaffe
Journal:  Pediatr Clin North Am       Date:  2002-04       Impact factor: 3.278

2.  An ethical perspective on the use of secure care for youth with severe substance use.

Authors:  Beth A Clark; Nina Preto; Bethan Everett; Jenny M Young; Alice Virani
Journal:  CMAJ       Date:  2019-02-19       Impact factor: 8.262

Review 3.  Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.

Authors: 
Journal:  Pediatrics       Date:  2016-08-22       Impact factor: 7.124

4.  Letter to the Editor in response to the article: Warshawski, T. and Warf, C. It is time for an ethical, evidence-based approach to youth presenting to the ED with an opioid overdose. Paediatr Child Health 2019;1-3. doi:10.1093/pch/pxz011.

Authors:  Catherine Farrell
Journal:  Paediatr Child Health       Date:  2019-07-01       Impact factor: 2.253

5.  Mortality Following Nonfatal Opioid and Sedative/Hypnotic Drug Overdose.

Authors:  Sidra Goldman-Mellor; Mark Olfson; Cristina Lidon-Moyano; Michael Schoenbaum
Journal:  Am J Prev Med       Date:  2020-05-07       Impact factor: 5.043

Review 6.  Medical decision-making in paediatrics: Infancy to adolescence.

Authors:  Kevin W Coughlin
Journal:  Paediatr Child Health       Date:  2018-04-12       Impact factor: 2.253

7.  Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.

Authors:  Rachel H Alinsky; Bonnie T Zima; Jonathan Rodean; Pamela A Matson; Marc R Larochelle; Hoover Adger; Sarah M Bagley; Scott E Hadland
Journal:  JAMA Pediatr       Date:  2020-03-02       Impact factor: 16.193

8.  It is time for an ethical, evidence-based approach to youth presenting to the ED with an opioid overdose.

Authors:  Tom Warshawski; Curren Warf
Journal:  Paediatr Child Health       Date:  2019-02-19       Impact factor: 2.253

9.  Medication for Adolescents and Young Adults With Opioid Use Disorder.

Authors: 
Journal:  J Adolesc Health       Date:  2021-01-21       Impact factor: 5.012

10.  Death after emergency department visits for opioid overdose in British Columbia: a retrospective cohort analysis.

Authors:  Jessica Moe; Mei Chong; Bin Zhao; Frank X Scheuermeyer; Roy Purssell; Amanda Slaunwhite
Journal:  CMAJ Open       Date:  2021-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.